Document detail
 Download  (537)
  View PDF  (807)
 Add to my MEDBOX

Nambia: NATIONAL GUIDELINES FOR MEDICINES SAFETY SURVEILLANCE

Ministry of Health and Social Services (MOHSS) (2011) C2
Therapeutics Information and Pharmacovigilance Centre | TIPC
Source:
https://www.rrfa.co.za/wp-content/uploads/2012/11/Medicines-Safety-Surveillance-Guidelines-Nov_2011.pdf
Topics:
medicines medicines safety pharmacovigilance monitoring of adverse effects adverse drug reactions namibia
Countries:
Namibia